CCND1 and prostate carcinoma: In prostate cancer, WWOX mediates G1 cell cycle arrest by downregulating cyclin D1 expression, which in turn suppresses the proliferation of 22Rv1 prostate cancer cells and inhibits tumor growth in nude mice [18].